Skip to content

Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)

Combination of Pulmonary Rehabilitation and Neuromuscular Electrical Stimulation and in COPD Patients: a Randomized Clinical Trial of Efficacy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00677690
Enrollment
83
Registered
2008-05-14
Start date
2007-01-31
Completion date
2009-01-31
Last updated
2011-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD

Brief summary

The purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).

Detailed description

Neuromuscular electrical stimulation (NMES) has been extensively used as technique to improve muscle function in different areas of rehabilitation, however it seems to be more appropriate in critical care situation, while its use in more able patients is of uncertain benefit. In other words, NMES seems to be particularly effective in severely deconditioned and bed ridden patients. We therefore carried out a randomised trial to compare the efficacy of combination of NMES and PR (NM+PR) with combination of sham stimulation and PR (SS+PR) in a large population of moderately impaired COPD patients. Primary outcome was evaluation of effect of NMES on quadriceps strength and on exercise capacity. Secondary outcome was evaluation of effect of NMES on symptoms (dyspnoea) and quality of life.

Interventions

OTHERneuromuscular electrical stimulation (NMES)

NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current. Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.

Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.

Sponsors

Fondazione Salvatore Maugeri
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of COPD * Must be able to walk

Exclusion criteria

* Previous or current diagnosis of chronic respiratory failure * A history of diseases other than COPD, in particular neurological disease * Need for treatment with systemic steroids during the rehabilitation period

Design outcomes

Primary

MeasureTime frameDescription
Exercise Capacity5 weeks6 minute walk test(6MWT)
Quadriceps Strength5 weeksQuadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.

Secondary

MeasureTime frameDescription
Dyspnoea5 weeksThe modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.
Quality of Life5 weeksSt. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).
Respiratory Function5 weeksforced expiratory volume in 1 second (FEV1)

Countries

Italy

Participant flow

Recruitment details

2007-2008 - Rehabilitative Pulmonary ward

Pre-assignment details

167 COPD patients were admitted.52 out of 167 did not meet the inclusion criteria.19 out of the remaining 115 patients refused to participate.13 out of 96 subjects subsequently dropped out due to acute exacerbation.Our definitive sample was therefore of 83 subjects

Participants by arm

ArmCount
Neuromuscular Stimulation and Pulmonary Rehabilitation
Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation
42
Pulmonary Rehabilitation
Patients undergone to pulmonary rehabilitation
41
Total83

Baseline characteristics

CharacteristicTotalNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
63 Participants31 Participants32 Participants
Age, Categorical
Between 18 and 65 years
20 Participants11 Participants9 Participants
Age Continuous62.1 years
STANDARD_DEVIATION 8.4
61.4 years
STANDARD_DEVIATION 7.6
62.8 years
STANDARD_DEVIATION 5.4
Region of Enrollment
Italy
83 participants42 participants41 participants
Sex: Female, Male
Female
23 Participants11 Participants12 Participants
Sex: Female, Male
Male
60 Participants31 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Exercise Capacity

6 minute walk test(6MWT)

Time frame: 5 weeks

ArmMeasureValue (MEAN)Dispersion
Neuromuscular Stimulation and Pulmonary RehabilitationExercise Capacity465.5 metersStandard Deviation 101.7
Pulmonary RehabilitationExercise Capacity462.7 metersStandard Deviation 96.9
p-value: <0.05t-test, 1 sided
Primary

Quadriceps Strength

Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.

Time frame: 5 weeks

ArmMeasureValue (MEAN)Dispersion
Neuromuscular Stimulation and Pulmonary RehabilitationQuadriceps Strength13.5 repetitionsStandard Deviation 0.83
Pulmonary RehabilitationQuadriceps Strength13.6 repetitionsStandard Deviation 0.99
p-value: <0.05t-test, 1 sided
Secondary

Dyspnoea

The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.

Time frame: 5 weeks

ArmMeasureValue (MEAN)Dispersion
Neuromuscular Stimulation and Pulmonary RehabilitationDyspnoea2.4 units on a scaleStandard Deviation 0.4
Pulmonary RehabilitationDyspnoea2.6 units on a scaleStandard Deviation 0.2
Comparison: All data were expressed as the mean ± SD. The level of significance for all tests was set at p \< 0.05.~Inter- and intra-group comparisons were performed using both paired and unpaired t tests for continuous variables and Chi squared for categorical variables.p-value: <0.05t-test, 1 sided
Secondary

Quality of Life

St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).

Time frame: 5 weeks

ArmMeasureValue (MEAN)Dispersion
Neuromuscular Stimulation and Pulmonary RehabilitationQuality of Life41.7 units on a scaleStandard Deviation 14.8
Pulmonary RehabilitationQuality of Life42.05 units on a scaleStandard Deviation 15.7
p-value: <0.05t-test, 1 sided
Secondary

Respiratory Function

forced expiratory volume in 1 second (FEV1)

Time frame: 5 weeks

ArmMeasureValue (MEAN)Dispersion
Neuromuscular Stimulation and Pulmonary RehabilitationRespiratory Function50.1 percentage of predicted valueStandard Deviation 6.4
Pulmonary RehabilitationRespiratory Function49.6 percentage of predicted valueStandard Deviation 8.2
p-value: <0.05t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026